-+ 0.00%
-+ 0.00%
-+ 0.00%

Aardvark Therapeutics Appoints David Zhang as Independent Director

PUBT·11/13/2026 13:02:20
Listen to the news
Aardvark Therapeutics Appoints David Zhang as Independent Director
  • Aardvark Therapeutics appointed David Zhang as an independent director in October 2026.
  • Zhang brings more than 25 years of experience, including oversight of CAMZYOS pivotal trial design at MyoKardia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130800PRIMZONEFULLFEED9877011) on November 13, 2026, and is solely responsible for the information contained therein.